Avantor, Inc. Agrees

PA 2026 Healthcare General

OIG False Claims Controlled Substance

Penalty

$5.3 million

Outcome

OIG enforcement action against Avantor, Inc. Agrees for false claims, controlled substance. Penalty: $5.3 million.

Details

Avantor, Inc. Agrees — OIG Enforcement (2026)

OIG took enforcement action against Avantor, Inc. Agrees in PA in 2026 involving false claims, controlled substance violations in the Healthcare General sector.

Penalty: $5.3 million

Violation types: False Claims, Controlled Substance
Entity type: Healthcare Provider
Penalty type: Settlement
Location: PA

Source: Avantor, Inc. Agrees To Pay $5.325 Million To Resolve Allegations Of False Claims For Overcharging Federal Agencies And Allegations Of DEA Violations And Lack Of Compliance As To Listed Chemicals

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.

Source: Avantor, Inc. Agrees To Pay $5.325 Million To Resolve Allegations Of False Claims For Overcharging Federal Agencies And Allegations Of DEA Violations And Lack Of Compliance As To Listed Chemicals

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works